Form 8-K - Current report:
SEC Accession No. 0001104659-25-074314
Filing Date
2025-08-06
Accepted
2025-08-05 17:39:47
Documents
14
Period of Report
2025-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2522626d1_8k.htm   iXBRL 8-K 27998
2 EXHIBIT 99.1 tm2522626d1_ex99-1.htm EX-99.1 273224
6 GRAPHIC tm2522626d1_ex99-1img001.jpg GRAPHIC 5865
  Complete submission text file 0001104659-25-074314.txt   502602

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cyrx-20250805.xsd EX-101.SCH 3014
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyrx-20250805_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyrx-20250805_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2522626d1_8k_htm.xml XML 3665
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)